Form 4: BioVie Inc. Director Richard J. Berman Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Director Richard J. Berman reported the acquisition of common stock and stock options in BioVie Inc.
Summary
- On November 20, 2024, Richard J. Berman, a director of BioVie Inc., reported acquiring 34,200 shares of common stock through a restricted stock unit (RSU) grant.
- The RSU grant was approved by the compensation committee and the board of directors.
- Each RSU represents a contingent right to receive one share of BioVie Inc.'s Class A common stock.
- The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting.
- Berman also acquired 23,155 stock options with an exercise price of $1.90, vesting in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026.
- Following these transactions, Berman beneficially owns 40,643 shares of common stock and 23,155 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions, indicating alignment of interests but not necessarily a strong positive or negative signal.
Positives
- The RSU grant and stock option acquisition indicate confidence from a director in the company's future performance.
- The vesting schedules for both the RSUs and stock options align the director's interests with the long-term success of the company.
Future Outlook
The vesting schedules of the RSUs and stock options suggest a long-term commitment from the director to the company's success.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the ownership structure and alignment of interests between management and shareholders.
Stakeholder Impact
- The acquisition of shares and stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Date of RSU grant and stock option acquisition |
| 12/20/2024 | First vesting date for stock options |
| 02/08/2025 | First vesting date for RSUs |
| 05/08/2025 | Second vesting date for RSUs |
| 08/08/2025 | Third vesting date for RSUs |
| 11/08/2025 | Fourth vesting date for RSUs (or earlier if 2025 annual shareholders' meeting occurs before) |
| 12/20/2025 | Second vesting date for stock options |
| 12/20/2026 | Third vesting date for stock options |
| 12/20/2029 | Expiration date for stock options |
| 01/07/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.